Recent News

• 02.12.2026 - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
• 02.06.2026 - Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
• 01.29.2026 - Anebulo Pharmaceuticals Announces Final Results of Tender Offer
• 01.27.2026 - Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
• 12.22.2025 - Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
• 11.13.2025 - Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Recent Filings

• 02.06.2026 - EX-99.1 EX-99.1
• 02.06.2026 - 8-K Current report
• 01.29.2026 - SC 13E3/A Going private transaction by certain issuers
• 01.29.2026 - EX-99.1 EX-99.1
• 01.29.2026 - 8-K Current report
• 01.27.2026 - EX-99.1 EX-99.1
• 01.27.2026 - SC 13E3/A Going private transaction by certain issuers
• 01.27.2026 - 8-K Current report
• 01.08.2026 - SC 13E3/A Going private transaction by certain issuers
• 12.22.2025 - EX-99.1 EX-99.1